| Microglial activation and tau propagate jointly across Braak stages TA Pascoal, AL Benedet, NJ Ashton, MS Kang, J Therriault, M Chamoun, ... Nature medicine 27 (9), 1592-1599, 2021 | 296 | 2021 |
| Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum AL Benedet, M Milà-Alomà, A Vrillon, NJ Ashton, TA Pascoal, F Lussier, ... JAMA neurology 78 (12), 1471-1483, 2021 | 235 | 2021 |
| Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative TK Karikari, AL Benedet, NJ Ashton, J Lantero Rodriguez, A Snellman, ... Molecular psychiatry 26 (2), 429-442, 2021 | 233 | 2021 |
| Association of apolipoprotein E ε4 with medial temporal tau independent of amyloid-β J Therriault, AL Benedet, TA Pascoal, S Mathotaarachchi, M Chamoun, ... JAMA neurology 77 (4), 470-479, 2020 | 190 | 2020 |
| 18F-MK-6240 PET for early and late detection of neurofibrillary tangles TA Pascoal, J Therriault, AL Benedet, M Savard, FZ Lussier, M Chamoun, ... Brain 143 (9), 2818-2830, 2020 | 161 | 2020 |
| Mild behavioral impairment is associated with β‐amyloid but not tau or neurodegeneration in cognitively intact elderly individuals FZ Lussier, TA Pascoal, M Chamoun, J Therriault, C Tissot, M Savard, ... Alzheimer's & dementia 16 (1), 192-199, 2020 | 125 | 2020 |
| Biomarker modeling of Alzheimer’s disease using PET-based Braak staging J Therriault, TA Pascoal, FZ Lussier, C Tissot, M Chamoun, G Bezgin, ... Nature aging 2 (6), 526-535, 2022 | 108 | 2022 |
| Determining amyloid-β positivity using 18F-AZD4694 PET imaging J Therriault, AL Benedet, TA Pascoal, M Savard, NJ Ashton, M Chamoun, ... Journal of Nuclear Medicine 62 (2), 247-252, 2021 | 77 | 2021 |
| Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography J Therriault, M Vermeiren, S Servaes, C Tissot, NJ Ashton, AL Benedet, ... JAMA neurology 80 (2), 188-199, 2023 | 69 | 2023 |
| APOEε4 potentiates the relationship between amyloid-β and tau pathologies J Therriault, AL Benedet, TA Pascoal, S Mathotaarachchi, M Savard, ... Molecular psychiatry 26 (10), 5977-5988, 2021 | 67 | 2021 |
| Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease B Bellaver, G Povala, PCL Ferreira, JP Ferrari-Souza, DT Leffa, ... Nature medicine 29 (7), 1775-1781, 2023 | 65 | 2023 |
| Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease JP Ferrari-Souza, PCL Ferreira, B Bellaver, C Tissot, YT Wang, DT Leffa, ... Molecular psychiatry 27 (11), 4781-4789, 2022 | 59 | 2022 |
| Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages TA Pascoal, AL Benedet, DL Tudorascu, J Therriault, S Mathotaarachchi, ... Brain 144 (11), 3517-3528, 2021 | 57 | 2021 |
| Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, APOE ε4, and Cognitive Impairment J Therriault, TA Pascoal, AL Benedet, C Tissot, M Savard, M Chamoun, ... Neurology 96 (7), e975-e985, 2021 | 49 | 2021 |
| Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer’s disease CM Cassidy, J Therriault, TA Pascoal, V Cheung, M Savard, L Tuominen, ... Neuropsychopharmacology 47 (5), 1128-1136, 2022 | 41 | 2022 |
| Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer’s disease T Terada, J Therriault, MSP Kang, M Savard, TA Pascoal, F Lussier, ... Molecular neurodegeneration 16, 1-12, 2021 | 41 | 2021 |
| Plasma pTau181 predicts cortical brain atrophy in aging and Alzheimer’s disease C Tissot, A L. Benedet, J Therriault, TA Pascoal, FZ Lussier, ... Alzheimer's Research & Therapy 13, 1-11, 2021 | 38 | 2021 |
| Association of plasma P-tau181 with memory decline in non-demented adults J Therriault, AL Benedet, TA Pascoal, FZ Lussier, C Tissot, TK Karikari, ... Brain Communications 3 (3), fcab136, 2021 | 36 | 2021 |
| Topographic distribution of amyloid-β, tau, and atrophy in patients with behavioral/dysexecutive Alzheimer disease J Therriault, TA Pascoal, M Savard, AL Benedet, M Chamoun, C Tissot, ... Neurology 96 (1), e81-e92, 2021 | 35 | 2021 |
| Comparing tau status determined via plasma pTau181, pTau231 and [18F] MK6240 tau-PET C Tissot, J Therriault, P Kunach, AL Benedet, TA Pascoal, NJ Ashton, ... EBioMedicine 76, 2022 | 34 | 2022 |
